3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Pancreatic Ductal
1
Anophthalmia with pulmonary hypoplasia
1
Interventions
Oxaliplatin
152
Fluorouracil
137
Gemcitabine
118
Bevacizumab
116
Leucovorin
106
Specimen Handling
105
Capecitabine
96
pembrolizumab
90
Magnetic Resonance Spectroscopy
83
Nivolumab
79
Cisplatin
79
Irinotecan
71
durvalumab
64
Cetuximab
62
Biopsy
61
Paclitaxel
60
130-nm albumin-bound paclitaxel
59
Radiotherapy
46
atezolizumab
45
Albumin-Bound Paclitaxel
37
Taxes
36
Carboplatin
36
Folfox protocol
35
Drug Therapy
32
Cyclophosphamide
30
lenvatinib
29
dehydroftorafur
29
tislelizumab
27
sintilimab
27
Radiation
26
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Long Interspersed Nucleotide Elements
×
Gastrointestinal
×
90 days
×
Clear all
NCT05475366
2026-05-01
PACsign
Institut Curie
Phase NA
Recruiting
85 enrolled